arrow_back Back to App

National Plan to End Parkinson's: Research, Treatment, and Support

This act establishes a nationwide project to prevent and cure Parkinson's disease and related conditions. This means more research, improved diagnosis, and better coordinated care, which can enhance the quality of life for affected individuals and their families, while also reducing financial burdens associated with treatment.
Key points
Establishment of the National Parkinson's Project to coordinate efforts in preventing and curing the disease.
Creation and regular updating of a national plan to combat Parkinson's, covering research, early diagnosis, and improved care.
Formation of an Advisory Council comprising experts, patients, and government representatives to advise on Parkinson's-related issues.
Annual reports to Congress assessing progress and recommending actions, including those aimed at reducing treatment costs for families and federal programs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8585
Sponsor: Rep. Tonko, Paul [D-NY-20]
Process start date: 2022-07-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

National Plan to End Parkinson’s Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8585.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-28.

What are the main provisions?

Key points include:

  • Establishment of the National Parkinson's Project to coordinate efforts in preventing and curing the disease.
  • Creation and regular updating of a national plan to combat Parkinson's, covering research, early diagnosis, and improved care.
  • Formation of an Advisory Council comprising experts, patients, and government representatives to advise on Parkinson's-related issues.
  • Annual reports to Congress assessing progress and recommending actions, including those aimed at reducing treatment costs for families and federal programs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Tonko, Paul [D-NY-20].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health